Atenção:
O eduCAPES é um repositório de objetos educacionais, não sendo responsável por materiais de terceiros submetidos na plataforma. O usuário assume ampla e total responsabilidade quanto à originalidade, à titularidade e ao conteúdo, citações de obras consultadas, referências e outros elementos que fazem parte do material que deseja submeter. Recomendamos que se reporte diretamente ao(s) autor(es), indicando qual parte do material foi considerada imprópria (cite página e parágrafo) e justificando sua denúncia.
Caso seja o autor original de algum material publicado indevidamente ou sem autorização, será necessário que se identifique informando nome completo, CPF e data de nascimento. Caso possua uma decisão judicial para retirada do material, solicitamos que informe o link de acesso ao documento, bem como quaisquer dados necessários ao acesso, no campo abaixo.
Todas as denúncias são sigilosas e sua identidade será preservada. Os campos nome e e-mail são de preenchimento opcional. Porém, ao deixar de informar seu e-mail, um possível retorno será inviabilizado e/ou sua denúncia poderá ser desconsiderada no caso de necessitar de informações complementares.
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Bersano, Paulo Ricardo de Oliveira | - |
Autor(es): dc.creator | Alves, Maria T. S. | - |
Autor(es): dc.creator | Gartner, Maria F. M. R. | - |
Autor(es): dc.creator | Ferrasi, Adriana Camargo | - |
Autor(es): dc.creator | Lima Neto, João Ferreira de | - |
Autor(es): dc.creator | Alvarenga, Fernanda da Cruz Landim e | - |
Autor(es): dc.creator | Vexenat, Stephane Cássia | - |
Autor(es): dc.creator | Alves, Carlos Eduardo Fonseca | - |
Autor(es): dc.creator | Silva, Glenda Nicioli da | - |
Autor(es): dc.creator | Rocha, Noeme Sousa | - |
Data de aceite: dc.date.accessioned | 2025-08-21T15:52:03Z | - |
Data de disponibilização: dc.date.available | 2025-08-21T15:52:03Z | - |
Data de envio: dc.date.issued | 2015-05-26 | - |
Data de envio: dc.date.issued | 2015-05-26 | - |
Data de envio: dc.date.issued | 2013 | - |
Fonte completa do material: dc.identifier | http://www.repositorio.ufop.br/handle/123456789/5546 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.4236/ojpathology.2013.34027 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/1026175 | - |
Descrição: dc.description | Experimental studies have shown that cyclo-oxygenase-2 (Cox2) is related to the development and pro-gression of tumors, since this enzyme is induced and expressed by cells such as macrophages, osteoblasts, “activated” endothelial cells, and tumor cells. The activity in tumors includes proliferation, cell transformation, tumor growth, inva- sion and metastasis and may play an important role in carcinogenesis of the canine osteosarcoma, since it has high ex- pression in tissue fragments. The combination of selective Cox2 inhibitors and other treatment modalities is the basis for a new anti-cancer therapy strategy. This in vitro study exposed primary cells of five different canine osteosarcoma cultures to selective Cox2 inhibitor at increasing concentrations and times. Results: For Cox2 negative cultures, despite the absence of differences, greater sensitivity of cells to treatment was observed. For Cox2 positive cultures, a higher number of necrotic cells were observed (P ≤ 0.05), when compared with negative cultures. For exposure times with Celecoxib doses, no difference (P > 0.05) was found between the three times analyzed for living, apoptotic and apop- totic/necrotic cells. There are similarities in the values of 24 h and 48 h, with slight reduction of living cells, increasing those undergoing apoptosis and apoptosis/necrosis. There was significance for necrosis (P ≤ 0.05). In 72 hours, a sig-nificant difference was observed between the other two previous values (P ≤ 0.05). It was found for the group of 100 μM•L−1, that there was a numerically greater signaling for apoptosis and lower (P = 0.08) for necrosis, and this point was the onset of the pharmacodynamic phenomenon, with drop in the values for living cells and increased number of necrotic cells, with a tendency (P = 0.08) for reducing the percentage of necrotic cells for the group of 100 μM•L−1 when compared to that of 10 μM•L−1. Conclusions: For Cox2 positive and negative cultures, there was difference for necrotic cells and there was no difference between Cox2 positive and Cox2 negative groups in relation to the percentage of living cells and apoptotic and apoptotic/necrotic cells. At time of 72 hours, higher percentage of living cells, lower percentage of apoptotic cells and increased percentage of necrotic cells in relation to groups of 24 and 48 hours were observed. A tendency for reducing the percentage of necrotic cells for the group of 100 μM•L−1 when compared to that of the group of 10 μM•L−1 was observed. | - |
Formato: dc.format | application/pdf | - |
Idioma: dc.language | en | - |
Direitos: dc.rights | O periódico Open Journal of Pathology permite o arquivamento da versão PDF do editor. Fonte: Sherpa Romeo <http://www.sherpa.ac.uk/romeo/issn/2164-6775/>. Acesso em: 03 jan. 2017. | - |
Palavras-chave: dc.subject | Canine | - |
Palavras-chave: dc.subject | Osteosarcoma | - |
Palavras-chave: dc.subject | Cyclo-Oxygenase-2 | - |
Palavras-chave: dc.subject | Celecoxib | - |
Título: dc.title | Role of selective cyclo-oxygenase-2 inhibitor celecoxib in canine osteosarcoma cell culture. | - |
Aparece nas coleções: | Repositório Institucional - UFOP |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: